Advancements with biologic and synthetic tissue technologies have resulted in myriad skin substitute product offerings. Healthcare professionals can feel overwhelmed by the number of choices and the variation of clinical applications for each. The experts at ECRI Institute have studied this class of products and remain at the forefront of assessing their clinical applications and market dynamics to help you make the best choices for the patient populations you serve.
This webinar will provide an overview of the main sources of skin substitutes derived from animal (e.g., bovine, porcine), human (e.g., placenta), and synthetic materials. We’ll explain what you need to understand about acellular versus cellular matrices and the implications for preventing immunologic responses. Our team will present the clinical evidence and current research across these categories. Another important area we’ll review is the changing FDA regulatory climate. These technologies are now categorized as minimally manipulated human cell and tissue products that are not subject to a regulatory pathway, but may be in the future.
In addition to the clinical use of skin substitutes, the ECRI PriceGuide™ team will deliver valuable market trends and insights on the more than 70 skin substitute products available. We’ll provide an overview of the various categories and manufacturers, including their market share and price trends. Let us help you make sense of it all.
1. Understand sources of skin substitutes and their clinical applications
2. Assess the regulatory environment and recent changes with FDA labeling
3. Identify the product options to best serve your patient demographics
4. Define market trends and price differentials
Who Should Attend
Wound care nurses, wound care clinics, ambulatory care clinics, clinicians involved in the care of diabetic patients, Value Analysis committee members, Supply Chain professionals, and Third-Party Payers